no image available Dickens & Co. "Breaking the Odds: Can Bevacizumab Revolutionize Glioblastoma Treatment?" "A Lifeline for Recurrent Brain Cancers: Bevacizumab's Promising Role in Glioblastoma Management" Price: 26.00€